Breaking News Instant updates and real-time market news.

MDT

Medtronic

$92.20

0.18 (0.20%)

, MASI

Masimo

$106.37

1.08 (1.03%)

10:19
12/19/18
12/19
10:19
12/19/18
10:19

Fly Intel: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Medtronic (MDT) upgraded to Overweight from Neutral at JPMorgan with analyst Robert Marcus saying that over the past year he's seen a "significant turnaround in performance" at Medtronic. 2. Masimo (MASI) upgraded to Overweight from Neutral at Piper Jaffray with analyst William Quirk saying management, during recent meetings, was upbeat about their near- and longer-term prospects of driving 8%-10% sales growth, at least 100 basis points of operating margin improvement and the company's 30% operating profit goal. 3. Darden (DRI) upgraded to Buy from Hold at Maxim and to Buy from Neutral at BTIG. 4. Best Buy (BBY) upgraded to Neutral, risks priced in, says MoffettNathanson with analyst Greg Melich saying sales and margin risks are reflected in valuation. 5. General Electric (GE) upgraded to Buy from Hold at Vertical Research. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

MDT

Medtronic

$92.20

0.18 (0.20%)

MASI

Masimo

$106.37

1.08 (1.03%)

DRI

Darden

$103.74

-0.08 (-0.08%)

BBY

Best Buy

$52.56

0.57 (1.10%)

GE

General Electric

$7.78

0.505 (6.95%)

  • 27

    Jan

MDT Medtronic
$92.20

0.18 (0.20%)

12/19/18
JPMS
12/19/18
DOWNGRADE
Target $118
JPMS
Neutral
JPMorgan sees 2019 as transition year for Zimmer, downgrades to Neutral
JPMorgan analyst Robert Marcus downgraded Zimmer Biomet Holdings (ZBH) to Neutral from Overweight and lowered his price target for the shares to $118 from $140. Despite the company's "favorable shifts in messaging and strategy," shares of Zimmer are set to end the year down as earnings estimates for 2019 and 2020 continue to move lower and its sales recovery is happening at a slower than expected pace, Marcus tells investors in a research note. He believes the company's sales growth will likely "remain depressed" throughout 2019 as it works to stabilize supply and get reps back on track. With 2019 "looking like another transition year," the analyst moves to the sidelines with respect the stock. Marcus coupled the downgrade of Zimmer Biomet with an upgrade of Medtronic (MDT) to Overweight.
12/19/18
JPMS
12/19/18
UPGRADE
Target $109
JPMS
Overweight
JPMorgan upgrades Medtronic to Overweight, boosts target to $109
JPMorgan analyst Robert Marcus upgraded Medtronic to Overweight from Neutral and raised his price target for the shares to $109 from $100. The analyst says that over the past year he's seen a "significant turnaround in performance" at Medtronic. Management has delivered four consecutive beat and raise quarters and "materially improved" free cash flow generation, Marcus tells investors in a research note. Over the next 12-18 months, the company can grow at least in line with its end-markets at 5% growth, contends the analyst. Plus, he believes a "number of underappreciated data presentations and transformative new product launches" do not appear to be fully appreciated by the Street. Marcus sees "meaningful upside" to Street estimates and the potential for multiple expansion on sustained execution.
12/19/18
JPMS
12/19/18
UPGRADE
Target $109
JPMS
Overweight
Medtronic upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Robert Marcus upgraded Medtronic to Overweight and raised his price target for the shares to $109 from $100. The analyst cites the company's "consistent" execution and "transformative" pipeline for the upgrade.
12/17/18
FBCO
12/17/18
INITIATION
Target $109
FBCO
Outperform
Medtronic initiated with an Outperform at Credit Suisse
Credit Suisse analyst Matt Miksic initiated Medtronic with an Outperform rating and a price target of $109 as part of his broader research note on Medical Supplies and Devices partially titled "No Disruption, No Alpha", saying the stock offers "favorable exposure" to Structural Heart and Robotic Surgery medicine. The analyst also believes that Medtronic is a "sustainable market leader" with an attractive portfolio of "emerging-and high-growth businesses organically and via tuck-in deals". Having integrated most of the Covidien assets, Miksic also expects Medtronic to be "more active on the M&A front".
MASI Masimo
$106.37

1.08 (1.03%)

09/14/18
09/14/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Shopify (SHOP) and Angi Homeservices (ANGI) initiated with an Outperform at Wedbush. 2. Griffon (GFF) initiated with a Neutral at Baird. 3. Genprex (GNPX) initiated with a Buy at Maxim. 4. Zogenix (ZGNX) initiated with a Buy at BofA/Merrill. 5. Masimo (MASI) initiated with a Buy at Needham. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/01/18
PIPR
11/01/18
NO CHANGE
Target $120
PIPR
Neutral
Masimo price target raised to $120 from $105 at Piper Jaffray
Piper Jaffray analyst William Quirk raised his price target for Masimo to $120 saying the company reported "another solid quarter." The analyst introduced his 2022 model, which calls for low double-digit product growth driven by the Philips relationship and new product introductions as well as ongoing pulse oximetry share gains. He keeps a Neutral rating on shares of Masimo, but would be "opportunistic with any pullbacks."
11/27/18
UBSW
11/27/18
INITIATION
UBSW
Buy
Masimo initiated with a Buy at UBS
UBS analyst Matthew Taylor initiated Masimo with a Buy rating and $137 price target, calling the stock a Top Buy for Growth/Momentum. Taylor said "analysis of Masimo's business and new product drivers suggest the upper end of this range (and cons) are a near term growth floor."
12/19/18
PIPR
12/19/18
UPGRADE
Target $120
PIPR
Overweight
Masimo upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst William Quirk upgraded Masimo to Overweight with an unchanged price target of $120. Management, during recent meetings, was upbeat about their near- and longer-term prospects of driving 8%-10% sales growth, at least 100 basis points of operating margin improvement and the company's 30% operating profit goal, Quirk tells investors in a research note. The analyst believes Masimo can drive leverage in excess of that in 2019 based on several existing and new initiatives started in 2018. The company is "set for a period of sustainable top- and bottom-line growth," says Quirk.
DRI Darden
$103.74

-0.08 (-0.08%)

12/18/18
BTIG
12/18/18
UPGRADE
Target $119
BTIG
Buy
Darden upgraded to Buy from Neutral at BTIG
BTIG analyst Peter Saleh upgraded Darden to Buy from Neutral with a price target of $119, citing its "continued top-line momentum and improved restaurant margin outlook". The analyst is positive on the company's sales initiatives, helping to reduce discounting while upgrading entries, and anticipates "more modest labor deleverage" as last year's workforce investments get lapped. Saleh adds that his prior concerns about the integration risk for Cheddar's as expressed in March of 2017 have not materialized, and he sees more upside in Darden stock price from continued sales momentum and earnings.
12/19/18
JPMS
12/19/18
NO CHANGE
Target $116
JPMS
Neutral
Darden pullback brings 'tactical buying opportunity,' says JPMorgan
JPMorgan analyst John Ivankoe keeps a Neutral rating on Darden Restaurants but views the recent share pullback as a "tactical buying opportunity." The analyst sees high margin visibility and raised his price target for Darden to $116 from $110 following the company's Q2 results. He believes investors should again look at Darden as "relatively lower-risk exposure to continued employment growth and wage expansion."
12/19/18
LOOP
12/19/18
NO CHANGE
Target $130
LOOP
Buy
Darden's solid Q2 result driven by better margins, says Loop Capital
Loop Capital analyst Lynne Collier kept her Buy rating and $130 price target on Darden after its "solid" Q2 results and raised guidance. The analyst notes that its earnings beat was driven by better margins, even with one-time items and a higher tax rate weighing on the bottom line. Collier sees Darden as one of her top picks in the industry based on its "best-in-class management team, continued market share gains supported by a superior value proposition, off-premise / menu innovation, significant economies of scale, and return of cash to shareholders."
12/19/18
MAXM
12/19/18
UPGRADE
MAXM
Buy
Darden upgraded to Buy from Hold at Maxim
Maxim analyst Stephen Anderson upgraded Darden to Buy from Hold.
BBY Best Buy
$52.56

0.57 (1.10%)

12/19/18
MOFT
12/19/18
UPGRADE
MOFT
Neutral
Best Buy upgraded to Neutral, risks priced in, says MoffettNathanson
MoffettNathanson analyst Greg Melich upgraded Best Buy to Neutral from Sell saying sales and margin risks are reflected in valuation.
12/17/18
12/17/18
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Best Buy (BBY) downgraded to Underperform from Neutral at BofA/Merrill analyst Curtis Nagle citing his caution about key product categories that include TVs, Apple (AAPL) products and gaming. 2. Illinois Tool Works (ITW) downgraded to Sell from Hold at Deutsche Bank. 3. Chesapeake Utilities (CPK) and Middlesex Water (MSEX) were downgraded to Neutral from Buy at Janney Montgomery Scott. 4. Callaway Golf (ELY) downgraded to Neutral from Buy at Roth Capital with analyst Dave King citing the recent acquisition of Jack Wolfskin and saying that the deal moves Callaway beyond its core competency in golf. 5. Centene (CNC) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Stephen Tanal citing risk associated with a potential adverse outcome in the Texas versus United States ACA ruling. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/17/18
12/17/18
DOWNGRADE
Target $50

Underperform
BofA/Merrill downgrades Best Buy to Underperform on industry slowdown concerns
As previously reported, BofA Merrill Lynch analyst Curtis Nagle downgraded Best Buy (BBY) to Underperform from Neutral, citing his caution about key product categories that include TVs, Apple (AAPL) products and gaming. Slowing industry growth, tough comparisons in key products and cost inflation will make upside less likely, contends Nagle, who has become more negative and now sees a higher possibility that Best Buy may see an "outright comp miss" in the fourth quarter. The analyst, who also believes consensus Street estimates for 2019/20 earnings are too high, lowered his price target on Best Buy shares to $50 from $70.
12/17/18
BOFA
12/17/18
DOWNGRADE
BOFA
Underperform
Best Buy downgraded to Underperform from Neutral at BofA/Merrill
GE General Electric
$7.78

0.505 (6.95%)

12/13/18
JPMS
12/13/18
UPGRADE
Target $6
JPMS
Neutral
General Electric upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Stephen Tusa upgraded General Electric to Neutral from Underweight with an unchanged price target of $6. The stock closed yesterday down 5c to $6.71. The analyst says he's less negative on the shares with the abating of "known unknowns." Tusa, however, increasingly assumes a "material equity raise could be necessary." While such an event would create near-term downside in GE shares, there "could be support at a lower level, and likely a benefit of the doubt for new management with a higher multiple on lower earnings" and free cash flow, Tusa tells investors in a research note partially titled "Gonna Walk Before They Make Me Run." The analyst sees a more balanced risk/reward following the recent selloff in General Electric shares.
12/13/18
12/13/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. General Electric (GE) upgraded to Neutral from Underweight at JPMorgan with analyst Stephen Tusa saying he's less negative on the shares with the abating of "known unknowns." 2. Five Below (FIVE) upgraded to Buy from Neutral at Goldman Sachs with analyst Christopher Prykull saying the 18% decline in the stock price over the past month is "disconnected" from the company's robust fundamentals and believes that there is a 20% upside to his price target. 3. Tractor Supply (TSCO) upgraded to Buy from Hold at Deutsche Bank with analyst Michael Baker citing valuation. 4. Procter & Gamble (PG) upgraded to Buy from Neutral at BofA/Merrill with analyst Olivia Tong saying after meetings with CFO Jon Moeller, she believes that the company's early momentum in Q1 of FY19 can be sustained. 5. Dycom (DY) upgraded to Buy from Hold at Craig-Hallum with analyst Christian Schwab saying he believes shares at current levels have become attractive again. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/19/18
VERT
12/19/18
UPGRADE
VERT
Buy
General Electric upgraded to Buy from Hold at Vertical Research
Vertical Research analyst Jeffrey Sprague upgraded General Electric to Buy from Hold with an $11 price target.
12/10/18
SUSQ
12/10/18
NO CHANGE
Target $24
SUSQ
Neutral
GE stake in Baker Hughes remains an overhang, says Susquehanna
Susquehanna analyst Charles Minervino said Baker Hughes (BHGE) management expressed optimism about its end market diversification, global oilfield footprint and robust backlog in recent meetings and noted the company has not made any changes to its outlook assumptions disclosed on the Q3 call. While he thinks Baker Hughes has done "a very admirable job" of managing the new organization since the GE (GE) merger, Minervino keeps a Neutral rating on the stock given the lingering GE 50.4% ownership overhang. After lowering his 2019 EPS estimate to $1.29 from $1.39 to account for model changes and the recent move in crude prices, Minervino lowered his price target on Baker Hughes shares to $24 from $31.

TODAY'S FREE FLY STORIES

TSM

TSMC

$50.14

-0.28 (-0.56%)

06:33
10/17/19
10/17
06:33
10/17/19
06:33
Hot Stocks
Breaking Hot Stocks news story on TSMC »

TSMC sees FY19 CapEx…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

TSM

TSMC

$50.14

-0.28 (-0.56%)

06:33
10/17/19
10/17
06:33
10/17/19
06:33
Earnings
TSMC sees Q4 revenue $10.2B-$10.3B, consensus $9.63B »

Gross profit margin is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

HON

Honeywell

$163.86

0.2 (0.12%)

06:33
10/17/19
10/17
06:33
10/17/19
06:33
Earnings
Honeywell reports Q3 adj. EPS $2.08, consensus $2.01 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

TSM

TSMC

$50.14

-0.28 (-0.56%)

06:32
10/17/19
10/17
06:32
10/17/19
06:32
Earnings
TSMC reports Q3 EPS 62c, consensus 60c »

Reports Q3 revenue $9.4B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

TXT

Textron

$50.52

-0.15 (-0.30%)

06:32
10/17/19
10/17
06:32
10/17/19
06:32
Earnings
Textron narrows FY19 EPS view to $3.70-$3.80 from $3.65-$3.85, consensus $3.74 »

The company revised its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

NFLX

Netflix

$286.83

2.59 (0.91%)

06:31
10/17/19
10/17
06:31
10/17/19
06:31
Recommendations
Netflix analyst commentary  »

Netflix price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

SNA

Snap-On

$157.68

-0.64 (-0.40%)

06:31
10/17/19
10/17
06:31
10/17/19
06:31
Earnings
Snap-On reports Q3 EPS $2.96, consensus $2.94 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

TXT

Textron

$50.52

-0.15 (-0.30%)

06:30
10/17/19
10/17
06:30
10/17/19
06:30
Earnings
Textron reports Q3 EPS 95c, consensus 85c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

IBM

IBM

$142.04

-0.94 (-0.66%)

06:29
10/17/19
10/17
06:29
10/17/19
06:29
Recommendations
IBM analyst commentary  »

IBM price target lowered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

MNST

Monster Beverage

$56.54

0.27 (0.48%)

06:28
10/17/19
10/17
06:28
10/17/19
06:28
Downgrade
Monster Beverage rating change  »

Monster Beverage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$189.62

0.81 (0.43%)

, PYPL

PayPal

$103.11

-0.43 (-0.42%)

06:28
10/17/19
10/17
06:28
10/17/19
06:28
Periodicals
Facebook's Marcus says Libra 'absolutely not' in jeopardy, Yahoo Finance reports »

Facebook's (FB)…

FB

Facebook

$189.62

0.81 (0.43%)

PYPL

PayPal

$103.11

-0.43 (-0.42%)

EBAY

eBay

$38.91

0.03 (0.08%)

BKNG

Booking Holdings

$2,028.24

10.61 (0.53%)

V

Visa

$177.87

-0.93 (-0.52%)

MA

MasterCard

$278.40

-0.24 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

NFLX

Netflix

$286.83

2.59 (0.91%)

06:27
10/17/19
10/17
06:27
10/17/19
06:27
Recommendations
Netflix analyst commentary  »

Netflix reported a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

MAT

Mattel

$11.50

0.105 (0.92%)

, WMT

Walmart

$119.44

-0.08 (-0.07%)

06:24
10/17/19
10/17
06:24
10/17/19
06:24
Periodicals
Walmart, Mattel 'lease floors' in KidHQ interactive store, WSJ reports »

Mattel (MAT) and Walmart…

MAT

Mattel

$11.50

0.105 (0.92%)

WMT

Walmart

$119.44

-0.08 (-0.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 13

    Nov

  • 14

    Nov

CXP

Columbia Property

$20.31

0.05 (0.25%)

06:24
10/17/19
10/17
06:24
10/17/19
06:24
Downgrade
Columbia Property rating change  »

Columbia Property…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 12

    Nov

GTLS

Chart Industries

$58.79

-0.38 (-0.64%)

06:23
10/17/19
10/17
06:23
10/17/19
06:23
Earnings
Chart Industries sees FY20 adjusted EPS $4.75-$5.25, consensus $5.06 »

Sees FY20 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 14

    Nov

AAPL

Apple

$234.59

-0.67 (-0.28%)

06:22
10/17/19
10/17
06:22
10/17/19
06:22
Recommendations
Apple analyst commentary  »

Apple price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

GTLS

Chart Industries

$58.79

-0.38 (-0.64%)

06:21
10/17/19
10/17
06:21
10/17/19
06:21
Earnings
Chart Industries lowers 2019 non-GAAP EPS view to $2.70-$2.90 from $2.85-$3.20 »

Consensus for 2019 EPS is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 14

    Nov

WLL

Whiting Petroleum

$6.65

-0.07 (-1.04%)

06:20
10/17/19
10/17
06:20
10/17/19
06:20
Downgrade
Whiting Petroleum rating change  »

Whiting Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 06

    Nov

LILA

Liberty Latin America

$18.14

0.14 (0.78%)

06:20
10/17/19
10/17
06:20
10/17/19
06:20
Upgrade
Liberty Latin America rating change  »

Barclays upgrades Liberty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$259.78

1.95 (0.76%)

06:19
10/17/19
10/17
06:19
10/17/19
06:19
Periodicals
Tesla granted car manufacturing certificate in China, Reuters reports »

China's industry…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

CXP

Columbia Property

$20.31

0.05 (0.25%)

06:19
10/17/19
10/17
06:19
10/17/19
06:19
Downgrade
Columbia Property rating change  »

Columbia Property…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 12

    Nov

GTLS

Chart Industries

$58.79

-0.38 (-0.64%)

06:18
10/17/19
10/17
06:18
10/17/19
06:18
Earnings
Chart Industries reports Q3 adjusted EPS 77c, consensus 77c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 14

    Nov

JNJ

Johnson & Johnson

$135.20

2.36 (1.78%)

, TEVA

Teva

$6.94

-0.02 (-0.29%)

06:17
10/17/19
10/17
06:17
10/17/19
06:17
Periodicals
J&J offers to pay $4B to settle opioid litigation, WSJ reports »

Johnson & Johnson…

JNJ

Johnson & Johnson

$135.20

2.36 (1.78%)

TEVA

Teva

$6.94

-0.02 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

TELNY

Telenor

$0.00

(0.00%)

06:15
10/17/19
10/17
06:15
10/17/19
06:15
Downgrade
Telenor rating change  »

Telenor downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

UN

Unilever; also tag UL

$59.71

1.25 (2.14%)

, UL

Unilever; also tag UN

$59.40

1 (1.71%)

06:14
10/17/19
10/17
06:14
10/17/19
06:14
Periodicals
Unilever cuts prices in U.S. amid shampoo rivalry with P&G, WSJ reports »

Unilever (UN, UL) CFO…

UN

Unilever; also tag UL

$59.71

1.25 (2.14%)

UL

Unilever; also tag UN

$59.40

1 (1.71%)

PG

Procter & Gamble

$116.77

0.3 (0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 22

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.